Abstract: Corticobasal syndrome (CBS) is a progressive disease that includes a heterogeneous neuropathological spectrum. In the majority of cases, corticobasal degeneration (CBD) is the underlying disease. Clinical heterogeneity is reflected in the clinical presentation of the syndrome and consequently misdiagnosis is common. Our case is of interest because the symptoms, the poor response to L-dopa and the I 123 Ioflupane CIT SPECT (DAT-SCAN) results were typical for CBD. However, the magnetic resonance imaging appearance suggested the possibility of a disease of vascular etiology. A 63-year-old woman presented in our outpatient clinic with symptoms of progressive clumsiness in the right arm when performing movements demanding fine motor skills, and mild speech difficulties. The brain magnetic resonance imaging (MRI) report described ischemic lesions in the left subcortical parietal areas, in the centrum semiovale, in periventricular white matter, cingulated gyrus bilaterally and moderate ventricle dilatation. A comprehensive neuropsychological study suggested mixed cortical and subcortical involvement. A DAT-SCAN examination showed a diminished dopamine transporter uptake in the left lenticular nucleus, suggesting parkinsonisn. For this patient, CBS-CBD was the most probable diagnosis, whereas vascular CBS was not excluded. This case report illustrates the low diagnostic sensitivity in predicting CBD and the overlap with other related neurodegenerative diseases. Finally, it demonstrates that in CBS, different underlying pathologies can be found at the same individual.
Introduction
Corticobasal syndrome (CBS) is a progressive disease that includes a heterogeneous neuropathological spectrum comprising corticobasal degeneration (CBD), Alzheimer disease (AD), progressive supranuclear palsy (PSP or Richardson's syndrome) and frontotemporal lobar degeneration, Creutzfeldt-Jacob disease, and vascular degenerative diseases [1] [2] [3] . In the majority of cases, CBD is the underlying disease. Clinical heterogeneity is reflected in the the clinical presentation of the syndrome. Consequently, it can be described as an asymmetric, akinetic, rigid syndrome with bradykinesia, limb dystonia, ideomotor limb apraxia, cortical sensory loss, non-fluent aphasia and cognitive impairment.
Case Report
A 63-year-old woman was admitted with clumsiness in the right arm when performing movements demanding fine motor skills; she noted that she had lost control over that arm. She also demonstrated mild speech diffi culties. The onset was insidious, starting 2 years prior and the course was slowly progressive. Her family history included no neurological disorders. Neurological examination demonstrated generalized bradykinesia, right upper limb dystonic posture, mild and infrequent myoclonic jerks, mild rigidity and mirror movements of the same limb when she was asked to perform a timed test with her left hand, as well as apraxia in performing fi ne motor skill movements. Her facial expressions were slightly subdued. Speech examination (spontaneous, naming, auditory comprehension, repetition reading and writing) revealed an anomic aphasia with occasional pauses of the speech caused by an inability to name. The remainider of her neurological examination was normal.
Routine biochemistry, hematology, cerebrospinal fl uid analysis (CSF) (protein, oligoclonal bands, and infective agents), serological antibodies and thyroid function tests results revealed no exceptional values. CSF analysis for the 42 amino acid form of amyloid β was inconclusive. Electroencephalography (EEG) examination revealed a slow, rhythmic wave activity without periodic or epileptiform discharges.
Brain magnetic resonance imaging (MRI) showed moderate dilatation of the lateral, third and fourth ventricles and lesions in left subcortical parietal areas, in the centrum semiovale, in periventricular white matter and cingulated gyrus bilaterally, which were described as ischemic. No hippocampal or brainstem atrophy was detected. There was no gadolinium enhancement ( Figure 1 ).
Comprehensive neuropsychological assessment revealed visuospatial abnormalities, complex attention dysfunction, working memory and executive function defi cits.
99m Tc-HMPAO SPECT is considered to be useful tool to detect the extent of cortical and subcortical involvement. In our patient 99m Tc-HMPAO SPECT showed asymmetrical hypoperfusion in the parietal, and to a lesser extent, in temporal areas and cerebellum that were more obvious in the left side ( Figure 2 ).
As the results were rather inconclusive, Ι 123 Iofl upane CIT SPECT (DAT-SCAN) examination was performed; it revealed a diminished dopamine transporter uptake in the left lenticular nucleus, suggesting parkinsonism ( Figure 3) .
She was treated with levodopa at dose of 300mg daily and experienced a mild remission of the bradykinesia.
The clinical diagnosis was that of CBD presenting with alien limb phenomenon. The diagnosis was based on the clinical manifestation, the gradual onset, the poor levodopa response and the DAT-SCAN fi ndings and was additionally supported by neuroimaging results and neuropsychological assessment [16] .
Discussion
The patient described here showed progressive clumsiness of the right arm, dystonic posture and ideomotor apraxia of the same limb and anomic aphasia. The MRI findings suggest a wide spectrum of progressive diseases that demonstrate cortical and subcortical "leukoenchephalopathic" lesions such as inflammatory, infective, progressive multifocal leukoencephalopathy (PML) or demyelinating diseases, to diseases with vascular involvement either of strategic infarct or subcortical ischemic vascular etiology. The results of neuropsychological evaluation, in combination with the clinical features of the patient, suggested mixed cortical and subcortical involvement. These findings are consistent with the CBS pattern. However, the DAT-SCAN image and the fact that CBD is the underlying disease in the majority of the CBS cases forced to the final diagnosis of CBD.
Typically, CBD begins after the sixth decade and the mean survival is 7 years after onset. Profound asymmetry is the characteristic hallmark of the syndrome presentation, affecting one limb, more frequently one arm. Although the existing diagnostic criteria for CBD are not formally validated and definitive diagnosis is made only after neuropathological confirmation, Watts et al suggested akinesia, rigidity, postural or gait disturbance, postural and action tremor, alien limb phenomenon, dystonia, myoclonus as the major criteria for the disease diagnosis and choreoathetosis, dementia, blepharospasm, and cerebellar signs (like supranuclear gaze abnormalities) as the minor ones [4, 5] . According to Riley et al, the clinical manifestations can be separated into those that appear as a result of basal ganglia impairment (eg akinesia, rigidity, dystonia, athetosis, postural instability), to those that have a cerebral cortex origin (eg alien limb phenomenon caused by cortical sensory loss, cognitive decline) and other features such as a postural-action tremor that often evolves to myoclonus, hyperreflexia, impaired ocular and eyelid motility, dysarthria and dysphagia [6] . The L-dopa response is poor. Other criteria that exclude a CBD diagnosis are the autonomic disturbances, the emergence of early vertical gaze palsy and the presence of structural damage on imaging studies [7] . It is a matter of conflict whether early dementia belongs to the exclusion criteria, as occasionally it appears as the prominent symptom of the disease [8, 12, 13, 29] . The main features of cognitive decline include apraxia and especially ideomotor apraxia and nonfluent aphasia. Neuropsychiatric manifestations such as depression, anxiety, irritability, delusions, and obsessive compulsive disorder are also common [9] .
Similar constellations of symptoms are described in different diseases (progressive supranuclear palsy, Pick's disease, frontotemporal dementia and parkinsonism linked to chromosome 17, frontotemporal lobar degeneration, Alzheimer's disease and Creutzfeldt-Jacob disease are the most common) that are embraced under the term CBS. The most problematic group, according to movement disorders specialists, is the one that consists of patients that resemble typical PSP. As they exhibit vertical supranuclear gaze palsy, early falls and symmetrical bradykinesia, this subgroup has been also described as having CBD-Richardson's syndrome. Other clinical manifestations of the syndrome that often lead to misdiagnosis are the asymmetrical tremulous parkinsonism with early postural instability, early amnestic signs and progressive non-fluent aphasia with behavioral or cognitive variant of frontotemporal degeneration [1, [10] [11] [12] [13] [14] . The sensitivity in predicting CBD remains low and varies from 26, 3% to 56% in different studies [1, [12] [13] [14] . There is no sufficient biomarker for the diagnosis of the disease, and the accurate diagnosis of CBD is provided by neuropathological criteria, as mentioned previously. The diagnosis is more or less based on the clinical experience of the specialists involved, whereas the role of the laboratory techniques and neuropsychological tests is supportive and useful to rule out other neurodegenerative disorders [15, 16] .
According to neuropsychological tests, in CBD the individuals typically present deficits in working memory (due to atrophy in both cortices and superior parietal areas), in spatial tasks and mild impaired sustained attention. Whereas in subcortical vascular dementias that simulate Alzheimer disease in the progressive cognitive decline, patients perform better on the delayed recall of both the verbal and visual memory test than do those with Alzheimer disease [16] [17] [18] [19] [20] [21] .
No abnormalities appear on conventional EEG, at least at the disease onset, although some patients may present a unilateral slowing [22] [23] [24] . J. Vion-Dury et al found significant modification of brain electrical activity in CBD. Authors attribute the discrepancies of the findings to the possible different stage of the disease and the various sensitivity of the individual technique to detect abnormalities [25] .
In the early phases of CBD the brain morphology is normal, but as the disease evolves more focal gray matter loss is demonstrated that is more prominent in the posterial frontal lobes of the most severely clinically affected side. Parietal lobe, corpus callosum and cerebral peduncles atrophy is also possible. Basal ganglia atrophy is common in both CBD and CBS with AD pathology. In the latter disease, gray matter loss is more obvious in posterior frontal, temporal, and superior and inferior parietal lobes. In CBD dementia, neuropsychological deficits are reflected by functional criteria and not the white matter lesions of MRI as long as atrophy has not occurred [26] [27] [28] . However, post-mortem studies have demonstrated that frontal lobe involvement is characteristic of CBD, as frequently frontal symptoms such as behavioral and cognitive disorders predominate at the disease initial stages [12, 13, 29] .
99m Tc-HMPAO SPECT is useful to differentiate CBD from other alternative diseases, because in CBD significant reduction of radiopharmaceutical uptake is in frontal, parietal, temporal cortices of the more affected side, in the thalamus and in pontocerebellar regions [30] [31] [32] 34] . In vascular dementias, hypoperfusion is confirmed in bilateral thalami, the anterior cingulate gyrus, the temporal gyri, the caudate heads and the left parahippocampal gyrus, suggesting functional disconnection between frontal lobes and subcortical structures [31] .
As definite diagnosis of CBD is very difficult and current tests are unable to differentiate CBS cases with CBD pathology from those without [35] , vascular CBS is not excluded according to the MRI, the 99m Tc-HMPAO SPECT results and the neuropsychological assessment.
This case report confirms the low diagnostic sensitivity in predicting CBD, which is consistent with the literature and shows the broad clinical spectrum that CBD exhibits [1, 2] . CBD can be regarded as one of the mentioned distinct degenerative entities and these diseases can also masquerade as CBD. In summary, it should be emphasized that CBS-CBD and CBS without CBD pathology (such as vascular CBS) can be two independent entities that co-exist within the same individual.
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